The Molecular Function of σ Receptors: Past, Present, and Future.

@article{Schmidt2019TheMF,
  title={The Molecular Function of $\sigma$ Receptors: Past, Present, and Future.},
  author={H. Schmidt and A. Kruse},
  journal={Trends in pharmacological sciences},
  year={2019}
}
The σ1 and σ2 receptors are enigmatic proteins that have attracted attention for decades due to the chemical diversity and therapeutic potential of their ligands. However, despite ongoing clinical trials with σ receptor ligands for multiple conditions, relatively little is known regarding the molecular function of these receptors. In this review, we revisit past research on σ receptors and discuss the interpretation of these data in light of recent developments. We provide a synthesis of… Expand

Topics from this paper

Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
TLDR
An up-to-date description of the medicinal chemistry of selective σ1R and σ2R ligands with antiproliferative and cytotoxic activities has been provided, including major pharmacophore models and comprehensive structure–activity relationships for each main class of σR ligand. Expand
Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives
TLDR
The evidence that some drugs in clinical use unintentionally bind the σ1 protein (as off-target) provides a proof of concept of the potential of the multi-targeted directed ligand (MTDL) approach, and it strongly supports the promise that the ρ1 receptor holds as a target to be hit in the context of MTDLs for the therapy of multifactorial pathologies. Expand
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
TLDR
This review provides up-to-date information on the selective targeting of σ1 receptors, including their history, function, reported crystal structures, and roles in neurological diseases, as well as a useful collation of new chemical entities as ρ1 selective orthosteric ligands or allosteric modulators. Expand
Enhanced Affinity for 3-Amino-Chromane-Derived σ1 Receptor Ligands
TLDR
36 phenethylamine-containing 3-amino-chromane ligands, which bind to σ1 with low nM affinities, are described, which show the potential for new therapies for cancer, pain management, neural degradation, and COVID-19. Expand
Virtual Screening for Ligand Discovery at the σ1 Receptor.
TLDR
High-throughput structure-based virtual screening is established as a highly effective platform for σ1 receptor ligand discovery and provides compounds to prioritize in studies of ρ1 biology. Expand
σ2 Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach
TLDR
This review aims to point out the progress regarding the σ2 ligands in the oncology field, with a focus on MTDLs directed towards ρ2 receptors as promising weapons against (resistant) cancer diseases. Expand
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ2R/TMEM97 ligands.
TLDR
A series of tetrahydroisoquinolino-2-alkyl phenone analogs are synthesized and it is identified that 10 of them have moderate to potent affinity and selectivity for σ2R/TMEM97. Expand
Sigma-2 Receptors: An Emerging Target for CNS PET Imaging Studies
The sigma-2 (σ2) receptor represents one of the most poorly understood proteins in cell biology. Although this receptor was identified through in vitro binding studies over 30 years ago, theExpand
Distinct Regulation of σ1 Receptor Multimerization by Its Agonists and Antagonists in Transfected Cells and Rat Liver Membranes
  • W. Hong
  • Chemistry, Medicine
  • The Journal of Pharmacology and Experimental Therapeutics
  • 2020
TLDR
It is reasoned that σ1R multimers possess high-affinity and high-capacity [3H](+)-pentazocine binding, whereas monomers likely lack binding, and may exist in interconvertible oligomeric states in a dynamic equilibrium. Expand
Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects
TLDR
A new series of benzylpiperazine-based σ1R antagonists has been designed, synthesized, and characterized for their affinities toward ρ1R and selectivity over the σ-2 receptor (σ2R). Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 121 REFERENCES
Structural basis for σ1 receptor ligand recognition
The σ1 receptor is a poorly understood integral membrane protein expressed in most cells and tissues in the human body. It has been shown to modulate the activity of other membrane proteins such asExpand
Identification of the gene that codes for the σ2 receptor
TLDR
Using a chemical biology approach, the σ2 receptor is purified from tissue, revealing its identity as TMEM97, an endoplasmic reticulum-resident transmembrane protein that regulates the sterol transporter NPC1. Expand
Crystal structure of the human σ1 receptor
The human σ1 receptor is an enigmatic endoplasmic-reticulum-resident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain. Recently,Expand
Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor.
TLDR
This work stably silenced or overexpressed PGRMC1 protein in human MCF7 adenocarcinoma cells and suggested that P GRMC1 and σ2 receptors are two different molecular entities. Expand
Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays
TLDR
Novel bioluminescence resonance energy transfer (BRET) assays that enable analyses of ligand‐induced multimerization of &sgr;1R and its interaction with BiP and both experimental and computational results support the topology revealed by the crystal structures of sigma 1 receptor. Expand
Sigma1 Pharmacology in the Context of Cancer.
TLDR
It is highlighted that although the literature supports a role for Sigma1 in cancer, several fundamental questions regarding drug mechanism of action and the physiological relevance of aberrant SIGMAR1 transcript and Sigma1 protein expression in certain cancers remain unanswered or only partially answered. Expand
Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
TLDR
These σR ligands have exhibited promising results against numerous human and rodent cancers and are investigated under preclinical and clinical study trials, indicating a new category of drugs in cancer therapy. Expand
Biochemical Pharmacology of the Sigma-1 Receptor
TLDR
The sigma-1 receptor is a promising drug target for the treatment of several neurodegenerative diseases related to cellular stress and the possibility that the S1R is a member of the small heat shock protein family is discussed. Expand
The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands*
TLDR
Results presented here support the proposal that S1R function may be regulated by its oligomeric state and possible mechanisms of molecular regulation of interacting protein partners by S1r in the presence of small molecule ligands. Expand
The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes
TLDR
In NSC34 cells devoid of or overexpressing PGRMC1, the maximum [3H]-DTG binding to the S2R as well as the DTG-protectable [125I]-IAF photolabeling of the S1R were similar to those of wild-type control cells. Expand
...
1
2
3
4
5
...